Latest ROE for Pharmagest Interactive S.A.: 35.4% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow35.40%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Pharmagest Interactive S.A. (PHA.PA) currently reports a ROE of 35.4%. That is above the sector sector average of 11.73%. Use the charts on this page to explore Pharmagest Interactive S.A.'s ROE history and peer comparisons.
Pharmagest Interactive S.A.'s ROE of 35.4% is higher than the its sector sector average of 11.73%. That is roughly 201.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Pharmagest Interactive S.A.'s current 35.4% should be judged against industry norms (sector average: 11.73%) and against PHA.PA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 35.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.73%. From there, open related valuation or income-statement pages for Pharmagest Interactive S.A., and consider following PHA.PA for alerts when major investors trade the stock.